Hjem › Tykktarmskreft › Massachusetts
Kliniske studier for Tykktarmskreft i Massachusetts
24 studier for Tykktarmskreft søker deltakere på steder i Massachusetts.
Byer i Massachusetts
Offisiell studietekst (engelsk)
Distance-Based Exercise to Preserve Function and Prevent Disability
- Dana-Farber Cancer Institute, Boston
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07059884A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Boston
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 29. sep. 2026 · NCT07127874Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Brigham and Women's Hospital (BWH), Boston
- Dana-Farber Cancer Institute (DFCI), Boston
- Dana-Farber Brigham Cancer Center - Foxborough, Foxborough
- og 2 flere
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 28. sep. 2026 · NCT07222800Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Dana Farber Cancer Institute, Boston
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06128551A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
- Massachusetts General Hospital - Main Campus, Boston
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07629960A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Massachusetts General Hospital, Boston
- Oncura Health, Boston
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07284849Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial
- Dana Farber Cancer Institute, Boston
Rekrutterer
Alder 18 til 50 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT06202183Resilience and Equity in Aging, Cancer, and Health (REACH)
- Dana-Farber Cancer Institute, Boston
Rekrutterer
Alder 65 og eldre · Alle kjønn · Oppdatert 10. sep. 2026 · NCT04674267Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- Massachusetts General Hospital Cancer Center, Boston
- Boston Veteran's Affairs Medical Center, Jamaica Plain
Rekrutterer
Alder 45 til 70 · Alle kjønn · Oppdatert 2. sep. 2026 · NCT05080673Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Beverly Hospital, Beverly
- Tufts Medical Center, Boston
- Dana-Farber Cancer Institute at Boston Medical Center - Brighton, Brighton
- og 7 flere
RekruttererFase 2/3
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT05174169Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
- Dana-Farber Cancer Institute, Boston
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 30. jun. 2026 · NCT07675967A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Mass General Brigham Cancer Institute at Massachusetts General Hospital, Boston
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 29. jun. 2026 · NCT07458347Integrated Cancer Repository for Cancer Research
- Holyoke Medical Center, Holyoke
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 19 til 110 · Alle kjønn · Oppdatert 29. jun. 2026 · NCT02012699A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, Boston
- Research Site, Boston
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 10. jun. 2026 · NCT06835569Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 3. jun. 2026 · NCT06040541A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Massachusetts General Hospital,, Boston
RekruttererFase 1/2
Alder 12 og eldre · Alle kjønn · Oppdatert 27. mai 2026 · NCT03093116Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Dana Farber Cancer Institute, Boston
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 15. mai 2026 · NCT05379985Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases
- Dana-Farber Cancer Institute, Boston
RekruttererTidlig fase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 13. mai 2026 · NCT02172651Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
- Dana Farber Cancer Institute, Boston
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 11. mai 2026 · NCT00843375Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Massachusetts General Hospital, Boston
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 6. mai 2026 · NCT06239194Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
- Dana-Farber Cancer Institute, Boston
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 7. jan. 2026 · NCT05773144Building Connections
- Disparities Research Unit, Massachusetts General Hospital, Boston
Rekrutterer
Alder 18 til 75 · Alle kjønn · Oppdatert 18. nov. 2025 · NCT07091032Eliminating Barriers to Colorectal Cancer Screening Using Rapid Cycle Testing: A Pilot Study
- Codman Square Health Center, Boston
- Brockton Neighborhood Health Center, Brockton
- East Boston Neighborhood Health Center, East Boston
- og 1 flere
RekruttererFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 14. nov. 2025 · NCT05524428SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Worcester
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.